TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ).
Imricor Medical Systems, Inc. announced the issuance of 144,526 CHESS Depositary Interests (CDIs) following the exercise of existing options, with these securities to rank equally with existing shares. This move is part of Imricor’s strategy to leverage section 708A of the Corporations Act for the sale of CDIs without disclosure to investors, reflecting the company’s compliance with relevant regulations and its ongoing efforts to enhance its market position and operational capabilities.
The most recent analyst rating on (AU:IMR) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. is a leader in the development of MRI-compatible products for cardiac catheter ablation procedures, aiming to improve the safety and effectiveness of interventional medical procedures by utilizing real-time MRI guidance instead of traditional x-ray fluoroscopy. Their flagship product, the Vision-MR Ablation Catheter, is designed to enhance treatment success rates and safety, and has received approval in the EU, Saudi Arabia, and New Zealand for treating type 1 atrial flutter. The company is working on expanding its product approvals in the U.S. and other Middle Eastern countries.
Average Trading Volume: 262,128
Technical Sentiment Signal: Buy
For detailed information about IMR stock, go to TipRanks’ Stock Analysis page.